What question did this study set out to answer?

To examine how COVID-19 interacts with preexisting cardiovascular comorbidities and contributes to heart failure progression.

April 10, 2020JACC Heart FailureOpen Access

COVID-19 Illness and Heart Failure

View Full Paper

Ask AI

Bookmark

To examine how COVID-19 interacts with preexisting cardiovascular comorbidities and contributes to heart failure progression.
Clinical analysis synthesizing observed epidemiological vulnerability patterns during the COVID-19 pandemic.
Evaluation of patient populations presenting with comorbid conditions including hypertension, diabetes mellitus, and coronary heart disease.
COVID-19 transmission demonstrates high viral efficiency across general populations but induces disproportionately severe disease in older cohorts.
Individuals with underlying cardiovascular disease, diabetes mellitus, and hypertension exhibit heightened vulnerability to life-threatening viral complications and heart failure.

Design

Editorial

Implication

Highlights the increased risk of severe COVID-19 progression in elderly patients with underlying cardiovascular conditions.

Abstract

In the throes of the COVID-19 crisis, a curious medical fact has emerged. The virus attacks universally and with high efficiency; however, its most menacing progression uniquely endangers the elderly, especially those with cardiovascular illness such as diabetes mellitus, hypertension, and coronary